Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0F5WP
|
||||
| Former ID |
DNC006053
|
||||
| Drug Name |
1-(2-aminoethyl)-1H-indazol-6-ol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527952] | ||
| Formula |
C9H11N3O
|
||||
| Canonical SMILES |
C1=CC2=CNN(C2=CC1=O)CCN
|
||||
| InChI |
1S/C9H11N3O/c10-3-4-12-9-5-8(13)2-1-7(9)6-11-12/h1-2,5-6,11H,3-4,10H2
|
||||
| InChIKey |
MURPCPKOPNSCMJ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [527952] | |
| 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [527952] | ||
| 5-hydroxytryptamine 2B receptor | Target Info | Inhibitor | [527952] | ||
| WikiPathways | Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | ||||
| Monoamine GPCRs | |||||
| GPCRs, Class A Rhodopsin-like | |||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| GPCR ligand binding | |||||
| GPCR downstream signalingWP733:Serotonin Receptor 2 and STAT3 Signaling | |||||
| SIDS Susceptibility Pathways | |||||
| GPCR downstream signaling | |||||
| GPCRs, OtherWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.